Dopamine Agonists for Pituitary Adenomas - Wikidata - awgldk - TriplyDB

Dopamine Agonists for Pituitary Adenomas

Dopamine Agonists for Pituitary Adenomas

http://www.wikidata.org/entity/Q58729410

about

Dopamine Agonists for Pituitary Adenomas

http://www.wikidata.org/entity/Q58729410

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Dopamine Agonists for Pituitary Adenomas

@en

Dopamine Agonists for Pituitary Adenomas

@nl

type

label

Dopamine Agonists for Pituitary Adenomas

@en

Dopamine Agonists for Pituitary Adenomas

@nl

prefLabel

Dopamine Agonists for Pituitary Adenomas

@en

Dopamine Agonists for Pituitary Adenomas

@nl

P1433

Q58729410-11366157-1E3E-46C1-8CDD-1D571804B7AD

P1476

Q58729410-AC9D6E95-4304-424E-BDBA-FB3C7225D61E

P2093

Q58729410-787E3B50-7B18-4256-9DA0-1F9FAE0CAA2F

Q58729410-835D3756-1F8D-4084-B663-87E6021B72BA

P2860

Q58729410-03D5ECB4-F490-4D1A-BD44-B6CDC06B0152

Q58729410-06E51ED5-F82F-48CF-B160-565BB063213A

Q58729410-0D815099-372C-45FC-87F6-44ACA8DBFFCB

Q58729410-1210EC6C-C1DA-4D12-B830-2D1423CAA42D

Q58729410-1EA03BEF-4665-4974-A811-B1F3545F5EE5

Q58729410-1F1EC4B3-1024-4758-A758-EFC613F4D2FB

Q58729410-2012C619-CC72-43E3-9F5A-2F7BCF8F073E

Q58729410-27AAD132-BC50-4B57-8495-7FCF22EA8573

Q58729410-2B136AA6-B961-443E-AD1C-0F046C169680

Q58729410-2CF0139E-FC26-4D24-8062-3F4CF2E0CAD7

P304

Q58729410-0C21AB5A-A370-4200-932A-971E959DF690

P31

Q58729410-0526ACBB-CE51-45A4-8189-D844E4F28EF9

P356

Q58729410-F9CCD1B8-85FD-4FAD-A9A4-2D9A5C4D0C7D

P407

Q58729410-3CBFD27B-F8AB-49A1-83B5-DBFE28C5036E

P478

Q58729410-C1CA47DA-7B00-44FB-838E-7B67E82E0C00

P577

Q58729410-E5CAA436-EBC0-44C8-BE53-4D9DF9DCAAE2

P698

Q58729410-2E50E586-D8C1-48F9-BAB8-BCC7C22CD0D9

P921

Q58729410-313872d3-83ab-41b7-bee4-030bd5489d21

P932

Q58729410-6C58FBF7-972C-431D-9D96-C01F23E6AC06

P356

FENDO.2018.00469

P1433

Frontiers in Endocrinology

P1476

Dopamine Agonists for Pituitary Adenomas

@en

P2093

Odelia Cooper

http://www.w3.org/2001/XMLSchema#string

Yona Greenman

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.

Management of clinically non-functioning pituitary adenoma

The Treatment of Cushing's Disease.

Valvular heart disease and the use of dopamine agonists for Parkinson's disease

Bromocriptine inhibits pro-opiomelanocortin mRNA and ACTH precursor secretion in small cell lung cancer cell lines

Beneficial effects of high daily dose bromocriptine treatment in Cushing's disease

Pituitary incidentaloma: an endocrine society clinical practice guideline.

Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity.

Control of lactotrop proliferation by dopamine: essential role of signaling through D2 receptors and ERKs.

The expression profile of Dopamine D2 receptor, MGMT and VEGF in different histological subtypes of pituitary adenomas: a study of 197 cases and indications for the medical therapy

P304

469

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FENDO.2018.00469

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30186234

http://www.w3.org/2001/XMLSchema#string

P921

P932

6110840

http://www.w3.org/2001/XMLSchema#string